![Frontiers | Effects of Clopidogrel, Prasugrel and Ticagrelor on Microvascular Function and Platelet Reactivity in Patients With Acute Coronary Syndrome Undergoing Coronary Artery Stenting. A Randomized, Blinded, Parallel Group Trial Frontiers | Effects of Clopidogrel, Prasugrel and Ticagrelor on Microvascular Function and Platelet Reactivity in Patients With Acute Coronary Syndrome Undergoing Coronary Artery Stenting. A Randomized, Blinded, Parallel Group Trial](https://www.frontiersin.org/files/Articles/780605/fcvm-08-780605-HTML/image_m/fcvm-08-780605-g001.jpg)
Frontiers | Effects of Clopidogrel, Prasugrel and Ticagrelor on Microvascular Function and Platelet Reactivity in Patients With Acute Coronary Syndrome Undergoing Coronary Artery Stenting. A Randomized, Blinded, Parallel Group Trial
![JCM | Free Full-Text | Switching Ticagrelor to 600 mg or 300 mg Clopidogrel Loading Bridge in Patients with Unstable Angina JCM | Free Full-Text | Switching Ticagrelor to 600 mg or 300 mg Clopidogrel Loading Bridge in Patients with Unstable Angina](https://www.mdpi.com/jcm/jcm-10-02463/article_deploy/html/images/jcm-10-02463-g001.png)
JCM | Free Full-Text | Switching Ticagrelor to 600 mg or 300 mg Clopidogrel Loading Bridge in Patients with Unstable Angina
![PDF) Switching Ticagrelor to 600 mg or 300 mg Clopidogrel Loading Bridge in Patients with Unstable Angina PDF) Switching Ticagrelor to 600 mg or 300 mg Clopidogrel Loading Bridge in Patients with Unstable Angina](https://www.researchgate.net/profile/Sinem-Cakal/publication/352070870/figure/fig1/AS:1030440756465664@1622687629909/Algorithm-for-switching-between-oral-P2Y12-inhibitors-in-the-acute-setting-LD-loading_Q320.jpg)
PDF) Switching Ticagrelor to 600 mg or 300 mg Clopidogrel Loading Bridge in Patients with Unstable Angina
![Frontiers | Dual Loading Antiplatelet Therapy in Patients With Acute Coronary Syndrome and High Bleeding Risk Undergoing Percutaneous Coronary Intervention: Findings From the Improving Care for Cardiovascular Disease in China Project Frontiers | Dual Loading Antiplatelet Therapy in Patients With Acute Coronary Syndrome and High Bleeding Risk Undergoing Percutaneous Coronary Intervention: Findings From the Improving Care for Cardiovascular Disease in China Project](https://www.frontiersin.org/files/MyHome%20Article%20Library/774123/774123_Thumb_400.jpg)
Frontiers | Dual Loading Antiplatelet Therapy in Patients With Acute Coronary Syndrome and High Bleeding Risk Undergoing Percutaneous Coronary Intervention: Findings From the Improving Care for Cardiovascular Disease in China Project
A Comparative Pharmacodynamic Study of Ticagrelor versus Clopidogrel and Ticagrelor in Patients Undergoing Primary Percutaneous Coronary Intervention: The CAPITAL RELOAD Study | PLOS ONE
![Comparison of Prasugrel and Ticagrelor Loading Doses in ST-Segment Elevation Myocardial Infarction Patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) Primary PCI Study - ScienceDirect Comparison of Prasugrel and Ticagrelor Loading Doses in ST-Segment Elevation Myocardial Infarction Patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) Primary PCI Study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109713003860-gr1.jpg)
Comparison of Prasugrel and Ticagrelor Loading Doses in ST-Segment Elevation Myocardial Infarction Patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) Primary PCI Study - ScienceDirect
![Dr. Sheila Sahni on Twitter: "Algorithm for switching between oral P2Y12 inhibitors in the acute and chronic setting. (For the Figure: LD = loading dose; MD = maintenance dose) Source: 2017 ESC Dr. Sheila Sahni on Twitter: "Algorithm for switching between oral P2Y12 inhibitors in the acute and chronic setting. (For the Figure: LD = loading dose; MD = maintenance dose) Source: 2017 ESC](https://pbs.twimg.com/media/DolJmHqUwAEInrl.jpg)
Dr. Sheila Sahni on Twitter: "Algorithm for switching between oral P2Y12 inhibitors in the acute and chronic setting. (For the Figure: LD = loading dose; MD = maintenance dose) Source: 2017 ESC
![Double (360mg) Loading Dose Of Ticagrelor In Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention | tctmd.com Double (360mg) Loading Dose Of Ticagrelor In Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention | tctmd.com](https://d18mqtxkrsjgmh.cloudfront.net/public/styles/large_slide_teaser/public/2013-02/116731.png?itok=TgPVr3HH)
Double (360mg) Loading Dose Of Ticagrelor In Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention | tctmd.com
![JCM | Free Full-Text | Pharmacodynamics and Outcomes of a De-Escalation Strategy with Half-Dose Prasugrel or Ticagrelor in East Asians Patients with Acute Coronary Syndrome: Results from HOPE-TAILOR Trial JCM | Free Full-Text | Pharmacodynamics and Outcomes of a De-Escalation Strategy with Half-Dose Prasugrel or Ticagrelor in East Asians Patients with Acute Coronary Syndrome: Results from HOPE-TAILOR Trial](https://pub.mdpi-res.com/jcm/jcm-10-02699/article_deploy/html/images/jcm-10-02699-g001-550.jpg?1624262586)
JCM | Free Full-Text | Pharmacodynamics and Outcomes of a De-Escalation Strategy with Half-Dose Prasugrel or Ticagrelor in East Asians Patients with Acute Coronary Syndrome: Results from HOPE-TAILOR Trial
![Low-dose ticagrelor yields an antiplatelet efficacy similar to that of standard-dose ticagrelor in healthy subjects: an open-label randomized controlled trial | Scientific Reports Low-dose ticagrelor yields an antiplatelet efficacy similar to that of standard-dose ticagrelor in healthy subjects: an open-label randomized controlled trial | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsrep31838/MediaObjects/41598_2016_Article_BFsrep31838_Fig1_HTML.jpg)
Low-dose ticagrelor yields an antiplatelet efficacy similar to that of standard-dose ticagrelor in healthy subjects: an open-label randomized controlled trial | Scientific Reports
![Low-dose ticagrelor yields an antiplatelet efficacy similar to that of standard-dose ticagrelor in healthy subjects: an open-label randomized controlled trial | Scientific Reports Low-dose ticagrelor yields an antiplatelet efficacy similar to that of standard-dose ticagrelor in healthy subjects: an open-label randomized controlled trial | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fsrep31838/MediaObjects/41598_2016_Article_BFsrep31838_Fig2_HTML.jpg)
Low-dose ticagrelor yields an antiplatelet efficacy similar to that of standard-dose ticagrelor in healthy subjects: an open-label randomized controlled trial | Scientific Reports
![Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial - The Lancet Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial - The Lancet](https://www.thelancet.com/cms/attachment/b6a2db3a-e8ab-4742-95fb-70b4d2fd6f8d/gr1_lrg.gif)
Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial - The Lancet
![Ticagrelor (Brilinta) for Secondary Prevention of Thrombotic Events Following Acute Coronary Syndrome | AAFP Ticagrelor (Brilinta) for Secondary Prevention of Thrombotic Events Following Acute Coronary Syndrome | AAFP](https://www.aafp.org/content/dam/brand/aafp/pubs/afp/issues/2013/1215/p821-ut1.gif)
Ticagrelor (Brilinta) for Secondary Prevention of Thrombotic Events Following Acute Coronary Syndrome | AAFP
![Transition between ticagrelor and two different doses of clopidogrel at hospital discharge in patients with acute coronary syndrome submitted to percutaneous coronary intervention | Revista Brasileira de Cardiologia Invasiva (English Edition) Transition between ticagrelor and two different doses of clopidogrel at hospital discharge in patients with acute coronary syndrome submitted to percutaneous coronary intervention | Revista Brasileira de Cardiologia Invasiva (English Edition)](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S2214123517300364:gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNc7ysTNkiDCBM6lVnNWyquHXlQrhWgK5rNoDJtKsulJzgBh4A6Lgm1IAJq45B/mR4snbG9B2/7SbHsVRbW0uQ3hsmGg/SX+gA1ST7hlCvqmkVsSSf6b4/hFejNS0CUpHdkd0vJ3Rh53T1oVVjKHlykfo1lo5VMFy4/e3yb++fwfd0MrmshdEGoLxsJ5HCk9GQ1rHXIl2dci1fGQzz9ynAgrZ23Y9LWJDAm9SfIOOw+NR0WWYhOQe/IYIY0Wiui4bu2LH8JQNmuyyvjVhwWTKAqG)
Transition between ticagrelor and two different doses of clopidogrel at hospital discharge in patients with acute coronary syndrome submitted to percutaneous coronary intervention | Revista Brasileira de Cardiologia Invasiva (English Edition)
![Effects of Crushed Ticagrelor Versus Eptifibatide Bolus Plus Clopidogrel in Troponin‐Negative Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Randomized Clinical Trial | Journal of the American Heart Association Effects of Crushed Ticagrelor Versus Eptifibatide Bolus Plus Clopidogrel in Troponin‐Negative Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Randomized Clinical Trial | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/7cb1f459-dbc9-4a6c-8636-1d3aadb2b1be/jah34520-fig-0001.png)
Effects of Crushed Ticagrelor Versus Eptifibatide Bolus Plus Clopidogrel in Troponin‐Negative Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Randomized Clinical Trial | Journal of the American Heart Association
![Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients with Acute Myocardial Infarction (IMPRESSION): study protocol for a randomized controlled trial | Trials | Full Text Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients with Acute Myocardial Infarction (IMPRESSION): study protocol for a randomized controlled trial | Trials | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13063-015-0724-z/MediaObjects/13063_2015_724_Fig1_HTML.gif)
Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients with Acute Myocardial Infarction (IMPRESSION): study protocol for a randomized controlled trial | Trials | Full Text
![Efficacy and safety of standard and low dose ticagrelor versus clopidogrel in east AsianPatients with chronic total occlusion undergoing percutaneous coronary intervention: a single center retrospective study | BMC Cardiovascular Disorders Efficacy and safety of standard and low dose ticagrelor versus clopidogrel in east AsianPatients with chronic total occlusion undergoing percutaneous coronary intervention: a single center retrospective study | BMC Cardiovascular Disorders](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12872-019-01307-0/MediaObjects/12872_2019_1307_Fig1_HTML.png)
Efficacy and safety of standard and low dose ticagrelor versus clopidogrel in east AsianPatients with chronic total occlusion undergoing percutaneous coronary intervention: a single center retrospective study | BMC Cardiovascular Disorders
![Comparison of Prasugrel and Ticagrelor Antiplatelet Effects in Korean Patients Presenting With ST-Segment Elevation Myocardial Infarction. | Semantic Scholar Comparison of Prasugrel and Ticagrelor Antiplatelet Effects in Korean Patients Presenting With ST-Segment Elevation Myocardial Infarction. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/fb588a93cdb2e141130a337c611bf3d2fc680490/2-Figure1-1.png)
Comparison of Prasugrel and Ticagrelor Antiplatelet Effects in Korean Patients Presenting With ST-Segment Elevation Myocardial Infarction. | Semantic Scholar
![Ticagrelor: Pharmacokinetics, Pharmacodynamics, Clinical Efficacy, and Safety - Dobesh - 2014 - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - Wiley Online Library Ticagrelor: Pharmacokinetics, Pharmacodynamics, Clinical Efficacy, and Safety - Dobesh - 2014 - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - Wiley Online Library](https://accpjournals.onlinelibrary.wiley.com/cms/asset/8e172e36-7a28-4ba3-9fd9-ca1adbcd512b/phar1477-fig-0003-m.jpg)
Ticagrelor: Pharmacokinetics, Pharmacodynamics, Clinical Efficacy, and Safety - Dobesh - 2014 - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - Wiley Online Library
![Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention | Circulation Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention | Circulation](https://www.ahajournals.org/cms/asset/412b1e26-bf57-42c6-9619-80a6c4ad68af/14ff1.jpg)